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Abstract
Background: Effectiveness and cost-effectiveness are increasingly important considerations in determining which
mental health services are funded. Questions have been raised concerning the validity of generic health status
instruments used in economic evaluation for assessing mental health problems such as depression; measuring
capability wellbeing offers a possible alternative. The aim of this study is to assess the validity of the ICECAP-A
capability instrument for individuals with depression.
Methods: Hypotheses were developed using concept mapping. Validity tests and multivariable regression analysis
were applied to data from a cross-sectional dataset to assess the performance of ICECAP-A in individuals who
reported having a primary condition of depression. The ICECAP-A was collected alongside instruments used to
measure: 1. depression using the depression scale of the Depression, Anxiety and Stress Scale (DASS-D of DASS-21);
2. mental health using the Kessler Psychological Distress Scale (K10); 3. generic health status using a common
measure collected for use in economic evaluations, the five level version of EQ-5D (EQ-5D-5L).
Results: Hypothesised associations between the ICECAP-A (items and index scores) and depression constructs were
fully supported in statistical tests. In the multivariable analysis, instruments designed specifically to measure
depression and mental health explained a greater proportion of the variation in ICECAP-A than the EQ-5D-5L.
Conclusion: The ICECAP-A instrument appears to be suitable for assessing outcome in adults with depression for
resource allocation purposes. Further research is required on its responsiveness and use in economic evaluation.
Using a capability perspective when assessing cost-effectiveness could potentially re-orientate resource provision
across physical and mental health care services.
Keywords: Patient reported outcome measures, Quality of life, Health economics
Background
For health services to prioritise mental health interventions,
both effectiveness and cost-effectiveness are key consider-
ations. Regulatory bodies such as the National Institute for
Health and Care Excellence (NICE) in England and Wales
have evolved methods for establishing cost-effectiveness
across both health and mental health interventions with the
use of economic evaluations [1]. The recommended
approach in measuring quality of life patient benefits for
economic evaluations has been to use generic, health fo-
cused patient reported outcome measures like EQ-5D [2, 3].
Once patients have completed such measures and popula-
tion preferences have been attached to patient reported
health states, health related quality of life (HRQoL) scores
are used to generate quality-adjusted life years (QALYs), a
composite measure accounting for the benefits of improved
morbidity and reduced mortality [4].
Depression results in the second largest disease burden
in terms of disability-adjusted life years (DALYs) globally
(DALYs are a similar, but slightly different measure to
QALYs [5]), with the condition also a major determinant
in suicide and associated with ischemic heart disease [6].
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Therefore, it is crucial for any provision of health care that
instruments used in deciding how to allocate resources
are able to assess the impact of depression on a person’s
quality of life and the improvements from providing treat-
ment and preventing the illness. Although recent findings
show HRQoL measures fare better in patients with
depression compared to other mental health groups such
as patients with bipolar disorder and schizophrenia, there
is an acknowledgement of the restricted coverage of
themes important to all mental health patients in the most
commonly used HRQoL measures: EQ-5D and SF-6D [7].
There are many critiques of QALYs. These include wor-
ries about the impact on equity of using QALY maximisa-
tion as the objective for economic evaluation [8–10] and
concerns about whether QALYs are fully able to capture
broader patient value from health care [11–14]. This latter
topic has received particular focus in the past decade with
unease about a sole reliance of just health related aspects
of quality of life, emanating from a number of different
research groups [15–17]. Nevertheless, the ability to use
QALYs to compare across very different health situations
has meant that it has retained its position of prominence,
in particular QALYs using EQ-5D [18]. A recent study
into the methods for assessing cost-effectiveness by NICE
found that the current standard approach leads to a
negative impact on QALYs forgone in a number of areas
including forgone gains from mental health services [19].
An alternative, relatively new approach for assessing
outcomes for individuals has emerged which focuses on
people’s capabilities [20]. The capability approach, devel-
oped most notably by Nobel prize winning economist
Amartya Sen, is primarily concerned with the evaluation
of individual advantage based on a person’s ability to
achieve ‘functionings’ in life that are valuable to them [20].
Examples of ‘functionings’ in the capability approach
range from basic attainments such as nourishment to
more complex attainments such as having self-respect. In
essence, the capability approach attempts to provide a
more encompassing picture of individuals when assessing
the impact of policy decisions upon them, than ap-
proaches that prefer to focus on “objects of convenience”,
such as income when assessing household and national
wellbeing [20].
The capability approach has been promoted by bioeth-
icists [21, 22], philosophers [23, 24], and health service
researchers [25, 26] who see the approach as a method
to assess impacts on an individual in an alternative
evaluative space than that of preference-based HRQoL
measures used to produce QALYs. This perspective has
also proved helpful in conceptualising mental health
problems. Hopper [27] found the capability perspective
accommodating when trying to determine social recov-
ery for patients with schizophrenia [27]. More recently,
other researchers have assessed Community Treatment
Orders for patients with mental health disorders (pre-
dominantly schizophrenia) through a capability lens by
developing a 16 item questionnaire [28] based on a list
of ten central human capabilities conceptualised by
eminent philosopher Martha Nussbaum [29].
The capability approach has gained recognition by NICE,
which has added capability measures to its reference case
for conducting economic evaluations where non-health
benefits are likely to accrue [1]. Currently, two capability
measures are recommended by NICE, an instrument for
social care known as Adult Social Care Outcomes Toolkit
(ASCOT) [30], and one of a generic family of instruments
developed originally from a grant called Investigating
Choice Experiences for the Preferences of Older People
(ICEpop), that has developed capability (CAP) instruments
for Adults (ICECAP-A), Older people (ICECAP-O) and a
Supportive Care Measure (ICECAP-SCM) for those in need
of palliative care (www.birmingham.ac.uk/icecap), with the
earliest developed measure (ICECAP-O) currently recom-
mended. If the same principles of comparability across
diseases are used for justifying the need for generic HRQoL
instruments when allocating resources across a health ser-
vice, a similar argument can be made for using the generic
ICECAP-A, the only index of capability currently developed
that could be applied across a broad range of patient groups
from populations of adults aged 18 years and older [31].
As a newly developed measure, evidence for the meas-
urement properties of the ICECAP-A in patient groups is
so far limited. It is important that any new outcome meas-
ure, including those used in economic evaluation, demon-
strates satisfactory measurement properties [32]. One test
of whether the measure is valid (i.e. it measures what it
purports to measure) is “construct validity”. This involves
testing mini-theories that are developed to explain the
relationship between the characteristic of interest (in this
case, capability) and other relevant characteristics of the
individual [33].
The overall aim of this work is to assess the validity of
the ICECAP-A measure in a sample of individuals suffer-
ing from depression. Validity in this study is assessed in
three ways. First, concept mapping, a qualitative construc-
tion of pathways or constructs between capability and
depression related items is developed based on a synthesis
of qualitative research in a mental health population [34].
The concept mapping framework then allows for the
formation of hypotheses about where a relationship is
expected between capability and depression related items.
Second, discriminant validity, the ability of a measure to
discriminate between identifiable groups, is tested by
using information about the ICECAP-A overall score in
relation to clinical cutoffs on two condition-specific ques-
tionnaires. Finally, multivariable regression is conducted
to compare the explanatory power of mental health items
and overall scores attached to the measure of capability
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(ICECAP-A) and the NICE recommended HRQoL meas-
ure for economic evaluation, the EQ-5D-5L [3]. This en-
ables an assessment of how a generic measure of capability
compares with the recommended HRQoL measure in eco-
nomic evaluation. Even though the measures are developed
using different underlying constructs, regression analysis
provides a means of comparing to current methodology
recommended by NICE for economic evaluation. We
hypothesise that more capability (through ICECAP-A) than
health status (through EQ-5D-5L) will be explained by
depression related items, because we expect the items on a
capability measure capturing “psychosocial well-being” will
have more in common for individuals with depression than
the “physical functioning” focused EQ-5D [35]. The three
methods of validity assessment use two measures closely
related to depression, the depression anxiety and stress
scale (DASS-21) [36] and the Kessler (K10) psychological
distress scale [37].
Methods
Data set and collection
The study uses data from a Multi Instrument Comparison
(MIC) cross sectional survey of individuals in eight health
categories (http://www.aqol.com.au) conducted between
November 2011 and May 2012. The survey was conducted
in six countries of which the four English speaking nations
(Australia, Canada, United Kingdom and United States)
were chosen for the present analyses (as the choice of these
countries did not raise issues associated with translation of
the measures). As well as a healthy population, seven broad
health condition populations were targeted. This study uti-
lises data from individuals who reported depression as
their primary condition, as well as the healthy population,
from the four English speaking nations [38].
The MIC survey was conducted online with panel
members using a global survey company, CINT Pty
Ltd. The personal and medical details recorded by the
company were used to recruit individuals from the
health condition groups. Quota sampling was con-
ducted for health condition groups to reach a total
number in each health condition group irrespective of
age, sex and education. The survey sought a sample of
150 individuals in each health condition area per coun-
try to ensure statistical power. Individuals were asked
to complete a relevant disease specific questionnaire
(two instruments for those with a diagnosis of depres-
sion) to confirm the existence of the illness and to
measure its severity. Choice of clinical measures for
each health condition was informed by expert opinion
of commonly used measures in the source country of
the MIC survey (i.e. Australia).
Ethics approval was obtained from Monash University
Human Research Ethics Committee (MUHREC Ap-
proval CF11/1758: 2011 00074). At the start of the MIC
survey, a Participant Information and Consent form was
provided. Proceeding with the survey was deemed as
provision of consent by the participant.
Measures
Capability measure
ICECAP-A The descriptive system for the ICECAP-A
instrument was developed in the UK using qualitative
methods [31]. The five capabilities captured by ICECAP-A
are phrased in terms of “being able to be” or “can have”
and are stability (“settled and secure”), attachment (“love,
friendship and support”), autonomy (“independent”),
achievement (“achieve and progress”) and enjoyment (“en-
joyment and pleasure”) (ICECAP-A available from
www.birmingham.ac.uk/icecap). These five items make up
the battery of questions in the ICECAP-A and they
attempt to capture broad concepts related to people’s cap-
ability to live a life that they value. The stability item con-
cerns informants’ desire for continuity in their lives when
it came to friends, work and location. The attachment
item emphasises how informants placed emphasis on love,
support and social contact. The autonomy attribute came
out of a desire to be one’s own person and not a liability
to others. The achievement attribute represents how infor-
mants placed value on moving forward in life and attain-
ing their goals. Finally, the enjoyment attribute tried to
capture everyday enjoyment that people want to be able
to have in their lives [31]. The attributes aim to capture
the capabilities that people value as distinct from the
factors that determine capability (e.g. income, health) [31].
Each capability item has four levels of responses. Once a
response level for each attribute is selected by the
patient, general population values can then be attached
to the patient’s current state. The use of population
values, as opposed to patient values, is the preferred
approach for health guidance bodies such as NICE [1].
The general population approach to valuing states
means that all possible individual states across a health
service can be, in theory, compared to one another. UK
population values have been developed for the ICECAP-A
[39]. The measure is anchored at 1 (full capability) and 0
(no capability). Values can range from 0 to 1.
The ICECAP-A has been validated for the general adult
UK population [40]. Additionally, a qualitative ‘think-
aloud’ investigation has been conducted to assess the ease
of interpretation and completion of the attributes of
capability captured on the ICECAP-A [41]. Content valid-
ity [42] and test-retest reliability of the instrument in the
general population have also been examined [43]. Respon-
siveness of the ICECAP-A has been assessed in an
osteoarthritis patient group [44]. As of January 2017, the
ICECAP-A was registered for use in 64 studies across 10
countries: Australia, Canada, China, Denmark, Ireland,
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Mexico, the Netherlands, New Zealand, the UK and the
USA. Originally developed in English, studies have or are
attempting to translate the measure into seven other
languages (Chinese, Dutch, French, German, Spanish,
Turkish and Welsh).
Condition-specific measures
Depression Anxiety and Stress Scale 21 item (DASS-
21) The Depression Anxiety and Stress Scale 21 item
(DASS-21) is an abbreviated version of the original DASS
42 item questionnaire [36]. It is a set of three self-report
scales (7 items per scale) that was designed to measure
the negative emotional states of depression, anxiety and
stress over the past week. The DASS-21 has been
validated in clinical [45] and non-clinical [46] samples.
The depression sub-scale (DASS-D), which is of primary
interest in this study, contains seven questions relating to
the dimensional syndromes associated with depression:
dysphoria (state of unease), hopelessness, devaluation of
life, self-depreciation, lack of interest/involvement, anhe-
donia (inability to experience pleasure) and inertia [36].
Each item is rated on a 4-part Likert scale, with scores
ranging from 0 to 3 per item, with higher scores reflecting
more severe states. Five severity levels (normal, mild,
moderate, severe and very severe) have been developed
Table 2 ICECAP-A responses from sample of individuals with depression (n = 617) and healthy population (n = 965)
Depression Healthy
1. Feeling settled and secure (STABILITY) n % n %
I am able to feel settled and secure in all areas of my life 35 5.7 365 37.8
I am able to feel settled and secure in many areas of my life 195 31.6 474 49.1
I am able to feel settled and secure in a few areas of my life 271 43.9 112 11.6
I am unable to feel settled and secure in any areas of my life 116 18.8 14 1.5
2. Love, friendship and support (ATTACHMENT)
I can have a lot of love, friendship and support 138 22.4 552 57.2
I can have quite a lot of love, friendship and support 214 34.7 317 32.8
I can have a little love, friendship and support 225 36.5 92 9.5
I cannot have any love, friendship and support 40 6.5 4 0.4
3. Being independent (AUTONOMY)
I am able to be completely independent 244 39.5 692 71.7
I am able to be independent in many things 249 40.4 244 25.3
I am able to be independent in a few things 100 16.2 24 2.5
I am unable to be at all independent 24 3.9 5 0.5
4. Achievement and progress (ACHIEVEMENT)
I can achieve and progress in all aspects of my life 73 11.8 437 45.3
I can achieve and progress in many aspects of my life 219 35.5 449 46.5
I can achieve and progress in a few aspects of my life 251 40.7 75 7.8
I cannot achieve and progress in any aspects of my life 74 12.0 4 0.4
5. Enjoyment and pleasure (ENJOYMENT)
I can have a lot of enjoyment and pleasure 62 10.0 519 53.8
I can have quite a lot of enjoyment and pleasure 183 29.7 374 38.8
I can have a little enjoyment and pleasure 334 54.1 68 7.0
I cannot have any enjoyment and pleasure 38 6.2 4 0.4
For the original ICECAP-A questionnaire, visit www.birmingham.ac.uk/icecap
Table 1 Key concepts underpinning the 5 items of the ICECAP-A measure
Stability Attachment Autonomy Achievement Enjoyment
Continuity of friends love look after oneself move forward in life quiet pleasures
Continuity of work support independence in decision-making attain goals fun
Continuity of location social contact privacy pride exciting
identity recognition and appreciation
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and those who score more highly display a number of
characteristics, such as being self-disparaging; dispirited,
gloomy and blue; convinced that life has no meaning; pes-
simistic about the future; unable to experience enjoyment
and satisfaction; unable to become interested or involved;
and slow, lacking in initiative [36].
Kessler Psychological Distress Scale (K10) The Kessler
Psychological Distress Scale 10 item (K10) was developed
for the US National Health Interview Survey to identify
people with a serious mental illness [37]. The question-
naire consists of 10 items measuring ‘psycho-social dis-
tress’ [37]. There is also a shortened 6 item version (K6)
[37]. There are five response levels for each question, with
scores ranging from 1 to 5 and higher scores representing
higher psychological distress. There are four severity levels
on the K10 (well, mild depression and/or anxiety disorder,
moderate depression and/or anxiety disorder and severe
depression and/or anxiety disorder). While primarily used
in non-clinical settings [47, 48], the K10 has also been
tested for detecting depression and anxiety disorders in
primary care [49].
Generic health status measure
EQ-5D-5L The EQ-5D-5L is an updated version of the
original EuroQol (EQ-5D) generic measure of health
status [2, 50]. The instrument is recognised as one of the
most widely used generic measures of health status. It
has been translated into 169 different languages. EQ-5D
data are routinely collected in some countries as well as
being used to inform healthcare decision-making [51].
The instrument has five dimensions (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression).
Each dimension has five response levels [3]. Preliminary
general population values for the EQ-5D-5L have been
developed from the three level version for a number of
countries [52], with research ongoing for new value sets
for the five level version. The measure is anchored at 1
(best health) and 0 (death), with a minimum value of
-0·594 for the UK value set. Values thus range from
-0·594 to 1. There has been one major study to date
assessing the validity of EQ-5D-5L compared to the ori-
ginal instrument across a variety of chronic conditions
including depression [53].
Analysis
Concept mapping from condition-specific and capability
items
Concept mapping is an approach used to organise and
analyse qualitative research findings and has been previ-
ously applied in mental health research [54]. We built a
conceptual framework to establish ‘pathways’ between
depression items and capability items and used concept
mapping to organise qualitative information into testable
quantitative hypotheses based on instrument completion
by people with depression. Data collected on capability
(using ICECAP-A) and depression (using DASS-D and
K10 condition-specific measures) from people reporting
depression as their primary condition were then used to
test these hypotheses and establish how depression was
likely to influence capability.
The pathways between condition-specific items and
ICECAP-A items were informed by a systematic review
of qualitative research in people with mental health
problems [34], to identify how mental health affected
quality of life and a person’s capability in people with
depression. In their study, Connell and colleagues [34]
identified six themes of quality of life that were of
importance for adults with mental health problems:
well-being and ill-being; control, autonomy and choice;
self-perception; belonging; activity; hope and hopeless-
ness [34]. These six themes each comprised 3 to 10
attributes that contributed to these respective aspects
of quality of life. For example, the self-perception
domain consisted of four related attributes: self-
identity/sense of self; self-efficacy; self-esteem; and self-
acceptance/self-stigma [34].
Table 3 Socio-demographic information for the sample of
respondents reporting depression
Key variables Sample Size (%)
Sex
Female 416 67.4
Male 201 32.6
Age
18-24 64 10.4
25-34 158 25.6
35-44 142 23.0
45-54 148 24.0
55-64 85 13.8
65+ 20 3.2
Highest Education
High School 215 34.8
Diploma/certificate/trade 214 34.7
University 188 30.5
Living with partner/spouse
Yes 341 55.3
No 276 44.7
Country of Residence
Australia 146 23.7
Canada 145 23.5
United Kingdom 158 25.6
United States 168 27.2
Total population = 617; ICECAP-A average = 0.637 (0.620,0.654);
EQ-5D-5L average = 0.593(0.572,0.614)
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To establish whether these intermediary mental health
themes identified by Connell et al. [34] related to
capability and depression, we used judgement informed
by expert opinion (SB, WK). Based on the qualitative
findings from the development of the ICECAP-A, three
to four key attributes per item were identified from Con-
nell and colleagues’ synthesis and attached to the five
capability items by PM, HA and JC (see Table 1) [31].
The items of DASS-D and K10 were also compared to
Connell’s 6 themes. PM used these qualitative themes to
develop hypotheses about likely relationships between
the ICECAP-A and the condition-specific instruments.
First, the ICECAP-A, DASS-D and K10 items were
individually compared to the quality of life themes and
attributes of the themes for people with mental health
problems identified by Connell and colleagues [34]. Step
1 assigned pathways between attributes from quality of
life themes and items on measures that were determined
by PM to be related to one another.
Step 2 drew upon the mappings established in Step 1
from Connell’s mental health themes to the three
instrument items, by then mapping between the ICECAP-
A items with the seven DASS-D items and the ten items
on the K10. A pathway between a depression item and a
capability item was hypothesised when a depression item
and capability item were linked to at least half of inter-
mediaries in common as identified by Connell and
colleagues. So, for example, an ICECAP-A item that con-
ceptually mapped onto two of the six themes identified by
Connell and colleagues [34], say ‘well-being, ill-being’ and
‘belonging’, would have an expected relationship with a
depression item on DASS-D mapped onto three mental
health themes, where two of these three themes included
the same two themes as mapped onto the ICECAP-A item
(80% or 4 of 5 themes in common). A relationship
between items on different measures would not hold if the
depression item, mapped onto three themes, only had one
of two themes in common with the capability item (40%
or 2 of 5 themes in common) (detailed explanation in
Additional file 1). This process was conducted initially by
PM and checked by SB and WK to assess whether the face
validity of these relationships would hold in a clinical
Table 4 Concept mapping DASS-D and ICECAP-A item relationships by mental health themes (%)
Stability Attachment Autonomy Achievement Enjoyment
Anhedonia 0.89 0.57 0.67 0.91 0.57
Inertia 0.75 0.33 0.75 0.80 0.67
Hopelessness 0.80 0.50 0.80 1.00 0.50
Dysphoria 0.89 0.57 0.89 0.91 0.57
Lack of interest/involvement 0.86 0.80 0.57 0.67 0.80
Self-depreciation 0.57 0.80 0.88 0.67 0.40
Devaluation of life 0.50 0.67 0.75 0.80 0.33
Relationships in bold where items between two measures have at least half of Connell’s mental health themes in common
Fig. 1 Concept mapping from DASS-21 depression Scale onto ICECAP-A capability attributes
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sample of patients with depression. The associations
between all ICECAP-A items and items on the condition-
specific questionnaires were assessed using chi-squared
tests (categorical variables) to assess these hypothesised
pathways.
Discriminant validity
Discriminant validity is used to test the ability of the
ICECAP-A to differentiate individuals classified with dif-
ferent existing severity levels on the condition-specific
questionnaires. It was expected that the ICECAP-A
index score would differ significantly between those clas-
sified in different depression severity levels on the
DASS-D (5 levels) and the K10 (4 levels). The difference
in means between severity groups is tested using the
Mann-Whitney U test.
Multivariable regression analysis
Finally multivariable regression analysis, using Ordinary
Least Squares (OLS), was used to assess the degree to
which overall capability (ICECAP-A) and health utility
(EQ-5D-5L) was explained by the items of (i) the DASS-
D; (ii) K10 and (iii) K6 (derived from the K10 responses).
It was expected that, if capability is better at capturing
the depression-related attributes of adults with depres-
sion than the EQ-5D-5L, the resultant R2 would be
higher for the overall capability models than for the
health status models. The R2 coefficient is a statistic that
shows, in this case, how well depression-related items
explain capability or health utility on a 0-1 scale, where
1 is capability fully explained by depression-related items
and 0 represents no relationship between depression
items and capability.
Results
In total, 617 individuals who reported depression as
their primary condition were included in the analysis.
Table 2 shows the distribution of the ICECAP-A
responses across the sample. As a comparator, responses
from a representative healthy population sample across
the same four countries (n = 965) are also included. In
terms of percentages, a higher proportion of the depres-
sion sample recorded responses on the lowest two levels
of capability across all five ICECAP-A items and a
higher proportion of the healthy population recorded
responses in the top two levels.
Table 3 presents socio-demographic information for
this sample. The average ICECAP-A score (0.637) is
Fig. 2 ICECAP-A scores and clinical cutoffs on condition-specific instruments. ICECAP-A: capability instrument on a scale of 1(full capability) to 0
(no capability); DASS-D, depression scale on the Depression, Anxiety and Stress Scale 21 item measure. K10, Kessler psychological distress scale.
DASS-D clinical cutoffs: normal (n = 112); mild (n = 71); moderate (n = 100); severe (n = 129); very severe (n = 205). K10 clinical cutoffs: well (n = 44);
mild (n = 68); moderate (n = 88); severe (n = 417). The error bars represent 95% confidence intervals around the mean
Table 5 Concept mapping K10 and ICECAP-A relationships by
mental health themes (%)
Stability Attachment Autonomy Achievement Enjoyment
K1 0.67 0.50 0.67 0.50 0.50
K2 0.33 0.50 0.67 0.50 0.50
K3 0.33 0.50 0.67 0.50 0.50
K4 0.80 0.50 0.80 1.00 0.50
K5 0.40 0.67 0.40 0.29 0.67
K6 0.40 0.67 0.40 0.29 0.67
K7 0.80 0.50 0.80 1.00 0.50
K8 0.75 0.40 0.75 0.80 0.67
K9 1.00 0.67 0.75 0.80 0.67
K10 0.57 0.80 0.86 0.67 0.40
K10, Kessler Psychological Distress Scale 10 item; k1, tired for no good reason;
k2, feel nervous;
k3, nervous so that nothing could calm you down; k4, hopeless; k5, restless
or fidgety;
k6, restless that you could sit still; k7, feel depressed; k8, everything was
an effort;
k9, so sad that nothing could cheer you up; k10, worthless. Relationships in
bold where items between two measures have at least half of Connell’s
mental health themes in common
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considerably lower for people with depression in this
sample than that from a general UK adult population
(≈0.83) [39, 40], and also lower than the “healthy popula-
tion” sample collected simultaneously in the same
dataset across the four countries (≈0.89) [55].
Concept mapping
In Fig. 1, based on the qualitative mapping exercise (see
Additional file 1 for full details), the expected pathways
between the five ICECAP-A items and the 7-item de-
pression scale on the DASS-21 questionnaire are shown.
Out of the 35 potential mappings from the depression
scale onto the ICECAP-A attributes (7x5 = 35), 32 were
expected to produce significant relationships (Table 4).
A similar process was conducted for the K10 and
ICECAP-A attributes. From the 50 potential relation-
ships, 40 were predicted through the mapping process to
produce significant relationships (Table 5). All 85 poten-
tial relationships were tested using chi-squared tests,
with all 85 relationships resulting in significant results
reporting a p-value of less than 0.05.
Discriminant validity
Figure 2 displays the ICECAP-A scores based on clinical
cut-offs using the Depression scale on DASS-21 [36] and
the K10 scale [37]. ICECAP-A mean values are able to
discriminate between severe and less severe states
(DASS-D very severe (0.47) and severe (0.64)), as well as
the normal/well group (DASS-D 0.84) from those classi-
fied in the mild group (DASS-D 0.71). There is not a
clear distinction of the ICECAP-A values between the
mild and moderate groups on both the DASS-D (both
0.71) and the K10 (mild 0.75, moderate 0.74).
In Tables 6 and 7, the models of capability and
health status from items on the DASS-D (Table 6),
K10 and K6 (Table 7) are presented. The R2 as a
method of explaining capability and health status
reveals that the condition-specific items contribute
more to the estimation of capability scores/values
than health status scores/values. In particular, 42.7%
of total capability value can be explained through the
DASS-D items, whereas the same DASS-D items
explains 30.2% of variation in health status in terms
of the EQ-5D-5L overall index score.
Scoring less well on the anhedonia and self-
depreciation items on DASS-D appears to contribute the
most to both poorer capability and health status values.
Scoring lower on the hopelessness item and higher on
the devaluation of life item also makes an important
contribution to the capability score. The highest and
lowest scores on the inertia item significantly contribute
to overall health status scores.
Table 6 Ordinary least squares regression of capability and
health status on DASS-D items
Dependent Variable
Independent Variable ICECAP-A S.E. EQ-5D-5L S.E.
Constant 0.710 0.050 0.729 0.066
Anhedonia
Many problems -0.086** 0.035 -0.153*** 0.045
Considerable problems -0.030 0.028 -0.091** 0.037
Some problems -0.016 0.023 -0.009 0.030
No problems
Inertia
Many problems -0.017 0.019 -0.054** 0.025
Considerable problems
Some problems 0.028 0.019 0.017 0.025
No problems 0.011 0.029 0.076** 0.038
Hopelessness
Many problems
Considerable problems 0.029 0.027 0.043 0.035
Some problems 0.074** 0.029 0.015 0.038
No problems 0.099*** 0.035 0.033 0.046
Dysphoria
Many problems 0.027 0.034 -0.056 0.045
Considerable problems 0.023 0.031 -0.079* 0.041
Some problems 0.026 0.026 -0.031 0.034
No problems
Lack of interest/involvement
Many problems -0.042 0.034 -0.063 0.045
Considerable problems -0.042 0.029 0.023 0.037
Some problems -0.040* 0.024 0.006 0.032
No problems
Self-depreciation
Many problems -0.140*** 0.036 -0.092* 0.047
Considerable problems -0.123*** 0.031 -0.070* 0.041
Some problems -0.080*** 0.026 -0.061* 0.034
No problems
Devaluation of life
Many problems -0.082*** 0.027 -0.027 0.036
Considerable problems
Some problems 0.001 0.023 0.015 0.030
No problems 0.019 0.029 -0.002 0.038
R2 0.427 0.302
Adjusted R2 0.407 0.277
S.E. standard error. *** p<0.01, ** p<0.05, *p<0.1
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Table 7 Ordinary least squares regression of capability and health status on K10 and K6 items
Dependent Variable
Independent Variable ICECAP-A S.E. EQ-5D-5L S.E. ICECAP-A S.E. EQ-5D-5L S.E.
Constant 0.506 0.085 0.402 0.103 0.669 0.075 0.537 0.091
Tired
Always 0.075** 0.036 0.019 0.044
Mostly 0.016 0.034 -0.032 0.041
Sometimes 0.060* 0.033 -0.003 0.040
A little
Never -0.023 0.091 -0.138 0.111
Nervous
Always -0.034 0.054 0.066 0.065
Mostly 0.019 0.047 0.095* 0.058 0.061** 0.025 0.058* 0.031
Sometimes -0.015 0.045 0.088 0.054 0.026 0.028 0.075* 0.033
A little 0.027 0.041 0.052 0.050 0.042 0.032 0.055 0.039
Never 0.017 0.045 0.011 0.055
Nervous/unease
Always 0.011 0.053 -0.127** 0.064
Mostly 0.057 0.042 -0.083 0.051
Sometimes 0.058 0.035 -0.045 0.043
A little 0.064** 0.030 -0.024 0.037
Never
Hopeless
Always
Mostly 0.067** 0.292 0.036 0.035 0.059** 0.028 0.061* 0.034
Sometimes 0.093** 0.036 -0.022 0.044 0.089** 0.035 0.019 0.042
A little 0.090** 0.042 -0.035 0.051 0.077** 0.041 0.010 0.049
Never 0.192*** 0.059 0.040 0.072 0.171*** 0.057 0.095 0.070
Restless/fidgety
Always 0.034 0.051 0.014 0.062 0.081** 0.041 0.007 0.050
Mostly -0.016 0.044 -0.016 0.053 0.030 0.037 0.000 0.045
Sometimes -0.039 0.040 0.002 0.049 0.007 0.035 0.030 0.043
A little -0.033 0.037 -0.007 0.045 0.002 0.034 0.016 0.042
Never
Restless/could not sit still
Always 0.047 0.046 -0.040 0.056
Mostly 0.033 0.037 -0.007 0.046
Sometimes 0.048 0.033 0.024 0.040
A little 0.040 0.028 0.017 0.035
Never
Depressed
Always
Mostly -0.016 0.025 0.072** 0.030
Sometimes 0.002 0.033 0.124*** 0.040
A little 0.018 0.041 0.158*** 0.050
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Discussion
This paper has attempted to assess the validity of a cap-
ability instrument for use in economic evaluation for
adults with depression, using two depression-related in-
struments and a widely used generic health status instru-
ment. All conceptually mapped relationships between
condition-specific items and capability attributes were
found to hold in statistical tests. The ICECAP-A scores
were also able to differentiate individuals with depres-
sion of different severity, using clinical cut-offs from the
normal to mild levels and moderate to severe levels. Fur-
ther, the depression specific items appeared to more fully
explain the ICECAP-A capability values than the health
status values obtained through the EQ-5D-5L, as dem-
onstrated in the multivariable regression analysis. Taken
together, these analyses suggest that using capability
measures provides one appropriate means of assessing
depression.
This study represents the first attempt to assess the
validity of using the ICECAP-A instrument specifically
for individuals with depression. The data are drawn from
four different nations, suggesting these results are gener-
alisable, at least across English speaking countries. The
study does have some limitations. The data collected
contain only information on individuals at one point in
time, so the responsiveness of the ICECAP-A instrument
could not be tested here. Due to the quota sampling
strategy undertaken in this study, it is unclear whether
the individuals analysed here are representative of people
with depression in the four countries included, but they
do provide a sample with a broad range of severities of
depression, which is helpful in assessing validity. This
study does not conceptually map onto the EQ-5D items,
as the main aim of this study was to validate the use of
ICECAP-A in people with depression. The performance
of EQ-5D in patients with depression and mental health
more generally has been comprehensively studied previ-
ously [7]. Indeed, the key mental health themes we con-
ceptually map the ICECAP-A items on are influenced by
a study that was conducted in response to perceived in-
adequacy of commonly used generic health measures
like EQ-5D [34]. Nonetheless, it is a limitation of this
study that we did not perform a similar concept map-
ping exercise onto EQ-5D items.
One difficulty with a newly developed questionnaire
outside traditional outcome measures, focusing on
broadly defined concepts such as capability, is that there
is no “gold standard” against which to assess criterion
validity. Measures of capability wellbeing, like ICECAP-
A, ultimately have a different normative basis to mea-
sures of health, like EQ-5D, and any decision about what
measure to use to guide healthcare resource allocation
Table 7 Ordinary least squares regression of capability and health status on K10 and K6 items (Continued)
Never 0.113 0.085 0.216** 0.104
Everything an effort
Always -0.084** 0.034 -0.147*** 0.041
Mostly 0.031 0.022 0.040 0.027 -0.069** 0.031 -0.107*** 0.037
Sometimes 0.075*** 0.027 0.096*** 0.033 -0.027 0.030 -0.032 0.036
A little 0.104*** 0.037 0.109** 0.045
Never 0.078 0.058 0.176** 0.071 -0.014 0.050 0.045 0.061
Low
Always
Mostly 0.036 0.028 0.112*** 0.034 0.038 0.027 0.136*** 0.033
Sometimes 0.036 0.033 0.103** 0.041 0.039 0.031 0.153*** 0.038
A little 0.051 0.040 0.109** 0.049 0.053 0.038 0.163*** 0.046
Never -0.020 0.053 0.052 0.065 -0.030 0.049 0.120** 0.060
Worthless
Always -0.222*** 0.053 -0.078 0.065 -0.235*** 0.052 -0.105 0.064
Mostly -0.137*** 0.049 -0.073 0.059 -0.159*** 0.048 -0.105* 0.058
Sometimes -0.107** 0.045 -0.025 0.055 -0.119*** 0.044 -0.053 0.054
A little -0.043 0.041 -0.027 0.049 -0.047 0.040 -0.039 0.049
Never
R2 0.372 0.343 0.340 0.316
Adjusted R2 0.329 0.298 0.313 0.288
Columns 2-5 for K10 models; Columns 6-9 for K6 models. S.E. standard error. *** p<0.01, ** p<0.05, *p<0.1
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must take this normative basis into account, as well
as the performance of the measure. A slight concern
could be raised with the similar scores seen for mild
and moderate depression in adults, although there is
no reason why changes in capability wellbeing should
be linearly related to depression. Indeed, an alterna-
tive interpretation could be that these data indicate
where the greatest impacts on capability are faced by
people with depression: between no depression and
mild depression; and between moderate depression
and severe depression.
Further research is required on the responsiveness of
the ICECAP-A measure for assessing potential benefits
of new interventions for patients with depression. It
would also be of benefit to assess the validity of the
ICECAP-A against alternative commonly used mea-
sures of depression (e.g. Beck Depression Inventory
[56]) and against other aspects of mental health. Based
on the findings from the multivariable regression ana-
lysis presented here, further research into the extent to
which generic capability and health status instruments
provide complementary information would be useful
[35, 57]. Finally, how measures of capability wellbeing,
such as the ICECAP-A, can be used in economic evalu-
ation to aid decision-making has been subject to recent
research [58, 59]. Even though progress has been made
with bodies like NICE now recommending capability
measures for economic evaluations in social care and in
the Netherlands for long-term conditions [60], more
research is necessary for such measures to be used both
within and beyond social care and also in applied eco-
nomic evaluations. There appears to be growing recog-
nition of the need to move beyond the current QALY
approach in health economics [17], with the capability
approach offering one viable alternative.
Conclusion
The ICECAP-A measure of capability wellbeing appears
to be suitable for assessing outcome in adults with de-
pression. This study offers a number of possible policy
implications. If a capability perspective were adopted in
economic evaluations across a health service, this study
suggests that changes in depression are more likely to
be captured and valued using a generic capability in-
strument than the commonly used generic health status
instrument, the EQ-5D (Tables 6 and 7). Provision for
services preventing and treating depression, and mental
health service provision more generally, is felt to play a
secondary and unequal role to physical health service
provision globally [61]. Using a capability perspective
when assessing cost-effectiveness could potentially re-
orientate resource provision across physical and mental
health care services.
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